Abstract
The chlamydial histone-like proteins, Hc1 and Hc2, function as global regulators of chromatin structure and gene expression. Hc1 and Hc2 expression and activity are developmentally regulated. A small metabolite that disrupts Hc1 interaction with DNA also disrupts Hc2 interactions; however, the small regulatory RNA that inhibits Hc1 translation is specific to Hc1.
The obligate intracellular bacterium Chlamydia trachomatis is the leading cause of infectious blindness worldwide (19) and the most prevalent bacterial agent of sexually transmitted disease in industrialized and developing countries (20). Chlamydiae undergo a unique biphasic developmental cycle, alternating between two developmental forms. Infection of the host cell is initiated by the metabolically inert elementary body (EB), which possesses a characteristic core of condensed chromatin. Following internalization, the chromatin becomes dispersed, transcription and translation are initiated, and EBs differentiate to the metabolically active reticulate bodies (RBs). RBs replicate for 18 to 48 h within a membrane-bound vacuole called an inclusion until they asynchronously differentiate to EBs, a process characterized by compaction of the chromatin. The EBs are released from the host cell, and a new round of infection begins (9, 15).
Two DNA binding proteins, Hc1 and Hc2, are believed to be responsible for the compaction of the chlamydial genome (4, 8, 12, 17). Hc1 and Hc2 (encoded by hctA and hctB, respectively) bear primary amino acid similarity to eukaryotic histone H1 and are expressed late in the developmental cycle concomitantly with RB-to-EB conversion and chromatin condensation (3, 15). Hc1 is conserved among the chlamydiae, while Hc2 displays variable molecular weight depending on the species (7, 13, 14, 16, 18). Overexpression of either of these two proteins in Escherichia coli results in compaction of the bacterial chromatin, although the ultrastructure of the DNA-protein complex is distinct (2, 4). In particular, overexpression of Hc1 in E. coli causes chromatin condensation ultrastructurally similar in appearance to the spherical condensed nucleoids of EBs (2), while overexpression of Hc2 induces a condensed nucleoid with a more toroidal appearance. Expression of Hc1 in E. coli leads to a down regulation of transcription, translation, and bacterial replication in conjunction with condensation of the chromatin (1). Hc1 and Hc2 have both been found to strongly repress transcription and translation in vitro by modulating DNA topology and/or binding to DNA and RNA (1, 10, 11).
The observed effects on chromatin structure and activity in E. coli are believed to reflect the native function of the histones in chlamydiae as they are considered to act as global regulators of chlamydial gene expression during the terminal differentiation of RBs to EBs at the end of the developmental cycle. Expression of the chlamydial histones in E. coli is effectively lethal, as E. coli apparently lacks the ability to release its chromatin from the constraints imposed by Hc1 or Hc2 binding.
Surprisingly, dispersal of the nucleoid requires chlamydial transcription and translation with negligible loss of Hc1. Because chlamydial dissociation of the histone-DNA complex requires transcription and translation, and as chlamydia lack a genetically tractable system, we designed a heterologous genetic screen to identify proteins involved in the regulation of Hc1 by selecting for chlamydial genes that relieved the lethal phenotype of Hc1 overexpression in E. coli. This selection identified two separate loci on the chlamydial genome that rescue E. coli from the growth restrictions imposed by Hc1 (5). The first locus, CT804, encodes IspE, an intermediate enzyme of the nonmevalonate, 2-C-methyl-d-erythritol-2,4-cyclodiphosphate (MEC) pathway of isoprenoid biosynthesis. E. coli coexpressing IspE and Hc1 grew normally, although it expressed Hc1 to a level equivalent to that which condensed the chromatin of parental Hc1-expressing controls. This situation is equivalent to that of germinating EBs in which the histone remains present but no longer functions in condensation of the chromatin. Deproteinated extract from IspE-expressing bacteria caused dispersal of purified chlamydial nucleoids, suggesting that chlamydial histone-DNA interactions are disrupted by a small metabolite in the methylerythritol phosphate pathway of isoprenoid biosynthesis rather than by direct action of IspE (5). The second locus encodes a small regulatory RNA (sRNA) that inhibits Hc1 translation but did not affect hctA mRNA transcription or stability (6). This sRNA is thought to act as an additional checkpoint to negatively regulate Hc1 synthesis. The chlamydial sRNA, IhtA (inhibitor of hctA translation), inhibits Hc1 translation during the exponential phase of chlamydial growth and is down regulated late in the chlamydial life cycle, concurrently with Hc1 translation and RB-to-EB differentiation (6). Because of the dramatic effects of Hc1 on chromatin structure and activity, Hc1 expression and activity thus appear to be tightly regulated transcriptionally as well as posttranscriptionally. Here we investigate whether these mechanisms of Hc1 regulation are specific for Hc1 or more general, including the other DNA binding protein, Hc2.
The condensed nucleoid of the EB disperses rapidly upon infection, and the EB is transcriptionally active within 2 hours of entry (15). Hc1 and Hc2 are late gene products whose transcription occurs only late in the developmental cycle (3, 8, 12, 15, 17). Hc1 levels remain essentially constant through the first 8 h of infection, decrease significantly by 12 h, and then increase between 18 and 20 h as RBs begin to differentiate to EBs (5). We analyzed C. trachomatis Hc2 during a 24-h infection by immunoblotting with a rabbit anti-Hc2 serum and densitometry. HeLa cells in 24-well plates were infected at a multiplicity of infection of approximately 500 to facilitate detection of Hc2 during the initial hours of infection. The chlamydial major outer membrane protein was included as a control for the level of infection. Hc2 levels remained constant during the first hour of infection and decreased slightly by 2 and 4 h. Thus, like Hc1, Hc2 is present during the initial nucleoid decondensation although presumably unable to bind to and condense the chromatin. Hc2 content decreased slowly until late gene expression was initiated between 18 and 20 h postinfection, and Hc2 levels increased with differentiation of RBs to EBs (Fig. 1) (3, 15).
Hc2 binds to and condenses DNA in vitro and condenses the chromatin upon expression in E. coli (4, 11). hctB, the gene encoding Hc2, was cloned into the pTet vector described previously (5) and expressed in E. coli DH5αPRO to verify condensation of the E. coli chromatin and determine the effects on viability. Expression of Hc2 (hctBpTet/pLac) in this system resulted in a 50% reduction in cell viability compared to an approximately 90% reduction in viability by Hc1 (Fig. 2A). Because expression of Hc2 in E. coli resulted in decreased viability, we were able to examine the ability of ispE and ihtA to restore viability when coexpressed with hctB. E. coli constructs expressing hctA (hctApTet/pLac), hctA and ispE (hctApTet/ispEpLac), and hctA and ihtA (hctApTet/ihtApLac) were included to control for IspE and IhtA activity. E. coli DH5αPRO, transformed with the indicated constructs, was grown in Luria-Bertani broth (LB) containing 100 μg ml−1 carbenicillin, 34 μg ml−1 chloramphenicol, and 50 μg ml−1 spectinomycin at 30°C. Overnight cultures were diluted to an optical density at 550 nm (OD550) of 0.2 and grown in the presence of 1 mM isopropyl-1-thio-β-d-galactopyranoside (IPTG) for 2 hours to induce IhtA and IspE production. Cultures were then split, and Hc1 or Hc2 protein expression was induced in one half by the addition of 100 ng ml−1 anhydrotetracycline for 5 h, at which point samples were diluted and plated on agar to assay cell viability (Fig. 2A). In agreement with previous results, expression of either ihtA or ispE with hctA rescued E. coli from the lethal effects of Hc1 expression. Coexpression of ispE with hctB (hctBpTet/ispEpLac) rescued E. coli from the repressive phenotype of Hc2 protein expression, suggesting that the same small molecule derived from the MEC pathway of isoprenoid biosynthesis also released Hc2 from the chromatin. Coexpression of ihtA with hctB (hctBpTet/ihtApLac) did not, however, rescue the repressed growth phenotype induced by Hc2 production (Fig. 2A). The effect of expression of both ispE and ihtA on Hc2 protein levels was assessed by immunoblotting (Fig. 2B). Cultures were normalized for OD550 prior to loading. Hc2 protein levels of ihtA-coexpressing cells (hctBpTet/ihtApLac) were similar to levels present in control samples that expressed hctB only (hctBpTet/pLac). This result is in agreement with the inability of ihtA expression to rescue the repressive phenotype of Hc2. In contrast, coexpression of ihtA with hctA (hctApTet/ihtApLac) resulted in Hc1 protein levels below the limits of detection (Fig. 2C) (6). Thus, the sRNA IhtA appears to specifically regulate hctA and has no effect on the regulation of hctB. In E. coli coexpressing hctB and ispE, Hc2 was present at levels similar to those in controls expressing Hc2 alone. Thus, although Hc2 was present at levels equivalent to those required to inhibit growth of the control (hctBpTet/pLac), it was unable to restrict growth when coexpressed with ispE. These results are similar to those previously reported (5) in which Hc1 protein levels of ispE-coexpressing E. coli (hctAptet/ispEpLac) approximate levels present in hctA-only-expressing cells (hctApTet/pLac) (Fig. 2C). Examination of the nucleoid structure by transmission electron microscopy confirmed the ability of Hc2 to condense the chromatin in cells expressing hctB only (Fig. 2D). E. coli coexpressing hctB and ispE had a chromatin structure identical to that of the vector-only control (pTet/pLac) despite the presence of Hc2 at levels sufficient to condense the chromatin of Hc2-only controls. E. coli coexpressing hctB and ihtA displayed a condensed chromatin structure identical to that of E. coli expressing hctB only (Fig. 2D).
The data suggest that the disruption of chlamydial histone-DNA interactions by the small molecule MEC upon initial infection is a general mechanism of histone-DNA release and functions to release both Hc1 and Hc2 from chromatin. The sRNA IhtA, on the other hand, regulates Hc1 synthesis specifically and has no regulatory effect on Hc2. Whether sRNA regulation of Hc2 or other chlamydial differentially expressed genes is a more general mechanism of developmental regulation in chlamydiae awaits additional experimentation.
Acknowledgments
This work was supported by the Intramural Research Program of the NIAID, NIH.
We thank T. Jewett, S. Grieshaber, and W. Jamison for review of the manuscript.
REFERENCES
- 1.Barry, C. E., III, T. J. Brickman, and T. Hackstadt. 1993. Hc1-mediated effects on DNA structure: a potential regulator of chlamydial development. Mol. Microbiol. 9:273-283. [DOI] [PubMed] [Google Scholar]
- 2.Barry, C. E., III., S. F. Hayes, and T. Hackstadt. 1992. Nucleoid condensation in Escherichia coli that express a chlamydial histone homolog. Science 256:377-379. [DOI] [PubMed] [Google Scholar]
- 3.Belland, R. J., G. Zhong, D. D. Crane, D. Hogan, D. Sturdevant, J. Sharma, W. L. Beatty, and H. D. Caldwell. 2003. Genomic transcriptional profiling of the developmental cycle of Chlamydia trachomatis. Proc. Natl. Acad. Sci. USA 100:8478-8483. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Brickman, T. J., C. E. Barry III, and T. Hackstadt. 1993. Molecular cloning and expression of hctB encoding a strain-variant chlamydial histone-like protein with DNA-binding activity. J. Bacteriol. 175:4274-4281. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Grieshaber, N. A., E. R. Fischer, D. J. Mead, C. A. Dooley, and T. Hackstadt. 2004. Chlamydial histone-DNA interactions are disrupted by a metabolite in the methylerythritol phosphate pathway of isoprenoid biosynthesis. Proc. Natl. Acad. Sci. USA 101:7451-7456. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Grieshaber, N. A., S. S. Grieshaber, E. R. Fischer, and T. Hackstadt. 2006. A small RNA inhibits translation of the histone-like protein Hc1 in Chlamydia trachomatis. Mol. Microbiol. 59:541-550. [DOI] [PubMed] [Google Scholar]
- 7.Hackstadt, T., T. J. Brickman, C. E. Barry III, and J. Sager. 1993. Diversity in the Chlamydia trachomatis histone homologue Hc2. Gene 132:137-141. [DOI] [PubMed] [Google Scholar]
- 8.Hackstadt, T., W. Baehr, and Y. Ying. 1991. Chlamydia trachomatis developmentally regulated protein is homologous to eukaryotic histone H1. Proc. Natl. Acad. Sci. USA 88:3937-3941. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Moulder, J. W. 1991. Interaction of chlamydiae and host cells in vitro. Microbiol. Rev. 55:143-190. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Pedersen, L. B., S. Birkelund, and G. Christiansen. 1994. Interaction of the Chlamydia trachomatis histone H1-like protein (Hc1) with DNA and RNA causes repression of transcription and translation in vitro. Mol. Microbiol. 11:1085-1098. [DOI] [PubMed] [Google Scholar]
- 11.Pedersen, L. B., S. Birkelund, and G. Christiansen. 1996. Purification of recombinant Chlamydia trachomatis histone H1-like protein Hc2, and comparative functional analysis of Hc2 and Hc1. Mol. Microbiol. 20:295-311. [DOI] [PubMed] [Google Scholar]
- 12.Perara, E., D. Ganem, and J. N. Engel. 1992. A developmentally regulated chlamydial gene with apparent homology to eukaryotic histone H1. Proc. Natl. Acad. Sci. USA 89:2125-2129. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Read, T. D., R. C. Brunham, C. Shen, S. R. Gill, J. F. Heidelberg, O. White, E. K. Hickey, J. Peterson, T. Utterback, K. Berry, S. Bass, K. Linher, J. Weidman, H. Khouri, B. Craven, C. Bowman, R. Dodson, M. Gwinn, W. Nelson, R. DeBoy, J. Kolonay, G. McClarty, S. L. Salzberg, J. Eisen, and C. M. Fraser. 2000. Genome sequences of Chlamydia trachomatis MoPn and Chlamydia pneumoniae AR39. Nucleic Acids Res. 28:1397-1406. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Read, T. D., G. S. Myers, R. C. Brunham, W. C. Nelson, I. T. Paulsen, J. Heidelberg, E. Holtzapple, H. Khouri, N. B. Federova, H. A. Carty, L. A. Umayam, D. H. Haft, J. Peterson, M. J. Beanan, O. White, S. L. Salzberg, R. C. Hsia, G. McClarty, R. G. Rank, P. M. Bavoil, and C. M. Fraser. 2003. Genome sequence of Chlamydophila caviae (Chlamydia psittaci GPIC): examining the role of niche-specific genes in the evolution of the Chlamydiaceae. Nucleic Acids Res. 31:2134-2147. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Shaw, E. I., C. A. Dooley, E. R. Fischer, M. A. Scidmore, K. A. Fields, and T. Hackstadt. 2000. Three temporal classes of gene expression during the Chlamydia trachomatis developmental cycle. Mol. Microbiol. 37:913-925. [DOI] [PubMed] [Google Scholar]
- 16.Stephens, R. S., S. Kalman, C. Lammel, J. Fan, R. Marathe, L. Aravind, W. Mitchell, L. Olinger, R. L. Tatusov, Q. Zhao, E. V. Koonin, and R. W. Davis. 1998. Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis. Science 282:754-759. [DOI] [PubMed] [Google Scholar]
- 17.Tao, S., R. Kaul, and W. M. Wenman. 1991. Identification and nucleotide sequence of a developmentally regulated gene encoding a eukaryotic histone H1-like protein from Chlamydia trachomatis. J. Bacteriol. 173:2818-2822. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Thomson, N. R., C. Yeats, K. Bell, M. T. Holden, S. D. Bentley, M. Livingstone, A. M. Cerdeno-Tarraga, B. Harris, J. Doggett, D. Ormond, K. Mungall, K. Clarke, T. Feltwell, Z. Hance, M. Sanders, M. A. Quail, C. Price, B. G. Barrell, J. Parkhill, and D. Longbottom. 2005. The Chlamydophila abortus genome sequence reveals an array of variable proteins that contribute to interspecies variation. Genome Res. 15:629-640. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Whitcher, J. P., M. Srinivasan, and M. P. Upadhyay. 2001. Corneal blindness: a global perspective. Bull. W. H. O. 79:214-221. [PMC free article] [PubMed] [Google Scholar]
- 20.World Health Organization. 2001. Global prevalence and incidence of selected curable sexually transmitted infections: overview and estimates, p. 1-43. World Health Organization, Geneva, Switzerland.